Adrian Crucefix has taken a 5.03% stake in Nativo Resources (LON: NTVO). The share price is two-fifths higher at 0.525p.
Fusion Antibodies (LON: FAB) is negotiating with the National Cancer Institute in the US concerning extending the OptiMAL project. The project has made progress in identifying antibody expressing cells as positively binding to their target of interest. This is validating the OptiMAL platform. The share price jumped 28.6% to 18p.
Quadrise (LON: QED) has successfully completed proof-of-concept an emissions testing for MSAR and bioMSAR on Everllence 4-stoke engines. The share price increased 21% to 3.8p.
Empire Metals (LON: EEE) has appointed Michael Tamlin as marketing manager to lead product strategy and end-user engagement. The partnership with TiPMC Consulting, which is providing titanium market insights. Managing director Shaun Bunn bought 40,000 shares at 36.25p. The share price rebounded 11.4% to 39p.
Fulcrum Metals (LON: FMET) has started phase 3 optimisation work with Extrakt at the Teck-Hughes mine tailings project. The results should be available in December. A phase 4 preliminary feasibility study will follow. The share price regained 15.5% to 5.6p.
Nexteq (LON: NXQ) has received its first major order for Quixant gaming hardware from the Brazilian state video lottery operator. The product was specifically designed for the market. Revenues will start to be generated in 2026. This will help to underpin longer-term forecasts. The share price improved 7.5% to 86p.
CPP Group (LON: CPP) has completed the sale of CPP India for $20m and $15m of that was paid upfront. The focus is the InsurTech business. The share price is 7.37% higher at 153p.
Predictive genetics company GENinCode (LON: GENI) says it knows of no reason for the recent share price rise. The interim results will be published on 30 September. The share price was above 5p, but it has fallen back to 4.05p, which is 5.47% higher.
FALLERS
Acoustic products supplier Autins Group (LON: AUTG) is suffering from volatile conditions in the automotive sector. In the five months to August 2025, revenues fell from £8m to £7.7m and the loss was reduced from £714,000 to £258,000. JLR is a major customer, and it has been hit by a cyber attack. JLR production stopped on 1 September and that will hold back Autins revenues. The share price slumped by two-fifths to 6p.
Healthcare communications technology developer Feedback (LON: FDBK) continues to suffer from slow decision making in the US. Results for the 12 months to May 2025 were in line with expectations at £886,000, down from £1.18m the previous year. There was a £3.19m impairment charge, taking the loss to £7.29m. The cost base is being reduced. Cash was £5.95m at the end of May 2025. Panmure Liberum downgraded 2025-26 expectations and forecasts a loss of £3.5m. Cash could fall to £2m. Winning contracts would improve prospects. The share price declined 11.3% to 11.75p.
Water mediation technology company Mycelx Technologies (LON: MYX) expects revenues to increase significantly in the first half. Interim revenues halved because of the sale of a business, but Mycelx Technologies is still on course to generate 2025 revenues of $12.5m with $11m already recognised or contracted. There are contracts in Nigeria and the Middle East. A reduced loss of $600,000 is forecast and net cash could be $1.1m at the end of the year. The share price fell 9.62% to 23.5p.
Premier African Minerals (LON: PREM) says the processing plant at the Zulu lithium and tantalum has achieved saleable concentrate on numerous occasions and the next phase it is undertaking further test work on optimising the plant to do this continuously. Limited mining has restarted. The share price decreased 7.14% to 0.026p.